Zapata Quantum, a hardware-agnostic pure-play quantum software company, has closed an oversubscribed $15 million strategic financing round led by Triatomic Capital, with participation from additional strategic investors. Odeon Capital Group acted as co-lead placement agent on the offering.
The raise marks the completion of a year-long restructuring effort for the Boston-based company, which trades on the OTC markets under the ticker ZPTA. Proceeds will be used to scale the company’s platform and team across science, engineering, product, and commercial functions.
Founded in 2017 out of Harvard’s Quantum Computing Lab, Zapata has built a portfolio of more than 60 granted and pending patents and has worked with Fortune 500 enterprises and government agencies across cryptography, pharmaceuticals, finance, materials discovery, and defense. The company is the only organization to have participated across all technical areas of DARPA’s Quantum Benchmarking program.
Zapata’s recent work in quantum-enabled drug discovery, conducted in collaboration with Dana-Farber Cancer Institute, the University of Toronto, and Insilico Medicine, was named one of Nature Biotechnology’s top 10 scientific papers of 2025 and featured on the journal’s December cover. The study focused on targeting the KRAS mutation in cancer therapy.
Zapata describes itself as an AI-native company and plans to leverage AI-driven development alongside a partnership with the University of Maryland on formal quantum algorithm validation to extend capabilities and maximize runway.
KEY QUOTES:
We’ve completed our restructuring and emerged stronger than ever. This financing is a strong vote of confidence from long-term, fundamentals-oriented investors and positions us to scale at a critical moment as quantum computing transitions from technical progress to transformational real-world value creation.
We are already firing on all cylinders: scientifically, technically, and commercially. This capital is jet fuel. It allows us to scale across every dimension.
Sumit Kapur, Chief Executive Officer, Zapata Quantum
Zapata stands out for its commitment to technical rigor, deep portfolio of foundational IP, and proven experience helping enterprises advance in their quantum journey. We’re proud to support Zapata’s growth as it continues to demonstrate leadership in translating quantum advantage into quantum utility.
Jeff Huber, General Partner, Triatomic Capital
